FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EZALLOR SPRINKLE (rosuvastatin) from Sun Pharmaceutical Industries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• EZALLOR SPRINKLE (ROSUVASTATIN)

Snippet

SUPPL AP for EZALLOR SPRINKLE (ROSUVASTATIN)